Arcturus Therapeutics Holdings Inc’s recently made public that its Chief Financial Officer SASSINE ANDY unloaded Company’s shares for reported $1.6 million on Jun 12 ’24. In the deal valued at $32.03 per share,50,000 shares were sold. As a result of this transaction, SASSINE ANDY now holds 220,526 shares worth roughly $4.74 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Chivukula Pad sold 114 shares, generating $5,130 in total proceeds. Upon selling the shares at $45.00, the Chief Scientific Officer & COO now owns 447,334 shares.
Before that, Chivukula Pad sold 26,000 shares. Arcturus Therapeutics Holdings Inc shares valued at $1,040,234 were divested by the Chief Scientific Officer & COO at a price of $40.01 per share. As a result of the transaction, Chivukula Pad now holds 447,448 shares, worth roughly $9.61 million.
Canaccord Genuity initiated its Arcturus Therapeutics Holdings Inc [ARCT] rating to a Buy in a research note published on December 13, 2023; the price target was $90. A number of analysts have revised their coverage, including William Blair’s analysts, who began to cover the stock in late July with a ‘”an Outperform”‘ rating. H.C. Wainwright also remained covering ARCT and has increased its forecast on May 11, 2023 with a “Buy” recommendation from previously “Neutral” rating.
Price Performance Review of ARCT
On Tuesday, Arcturus Therapeutics Holdings Inc [NASDAQ:ARCT] saw its stock fall -9.21% to $21.48. Over the last five days, the stock has lost -18.23%. Arcturus Therapeutics Holdings Inc shares have fallen nearly -31.87% since the year began. Nevertheless, the stocks have fallen -25.10% over the past one year. While a 52-week high of $45.00 was reached on 06/05/24, a 52-week low of $17.52 was recorded on 07/02/24. SMA at 50 days reached $29.96, while 200 days put it at $29.55. A total of 1.33 million shares were traded, compared to the trading of 1.18 million shares in the previous session.
Levels Of Support And Resistance For ARCT Stock
The 24-hour chart illustrates a support level at 19.92, which if violated will result in even more drops to 18.36. On the upside, there is a resistance level at 23.64. A further resistance level may holdings at 25.80. The Relative Strength Index (RSI) on the 14-day chart is 29.38, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -3.54, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 92.97%. Stochastics%K at 6.02% indicates the stock is a buying.
